Assessment of the Plans to Optimize Antimicrobial Use in the Pediatric Population in Catalan Hospitals: The VINCat Pediatric PROA SHARP Survey
Borja Guarch-Ibáñez,
Aurora Fernández-Polo,
Sergi Hernández,
Eneritz Velasco-Arnaiz,
Montse Giménez,
Pere Sala-Castellvi,
Valentí Pineda,
Susana Melendo,
VINCat Pediatric PROA Group
Affiliations
Borja Guarch-Ibáñez
Pediatric Infectious Diseases Unit ICS-IAS, Department of Pediatrics, Hospital Universitari de Girona Dr. Josep Trueta, Universitat de Girona, 17007 Girona, Spain
Aurora Fernández-Polo
Department of Pharmacy, Hospital Universitari Vall d’Hebron, Vall d’Hebron Research Institute, Universidad Autónoma de Barcelona, 08035 Barcelona, Spain
Sergi Hernández
VINCat Program Surveillance of Healthcare Related Infections in Catalonia, 08907 Barcelona, Spain
Eneritz Velasco-Arnaiz
Antimicrobial Stewardship Program (PROA-SJD), Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Sant Joan de Déu, 08950 Barcelona, Spain
Montse Giménez
Department of Microbiology, Laboratori Clínic de la Metropolitana Nord, Hospital Germans Trias i Pujol, 08916 Badalona, Spain
Pere Sala-Castellvi
Department of Paediatrics, Hospital Universitari General de Catalunya, 08915 Sant Cugat del Vallés, Spain
Valentí Pineda
Pediatric Infectious Diseases Unit, Department of Pediatrics, Hospital Universitari Parc Taulí, Universidad Autónoma de Barcelona, 08208 Barcelona, Spain
Susana Melendo
Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Infantil Vall d’Hebron, Vall d’Hebron Research Institute, 08035 Barcelona, Spain
In Spain, many programs have been introduced in recent years to optimize antimicrobial stewardship in pediatric care (known as pediatric PROA). However, information on the current situation of these programs is scarce. The present study assesses current antimicrobial use in pediatric care in the hospitals of Catalonia affiliated with the VINCat pediatric PROA group. Between December 2020 and January 2021, an electronic survey related to the design and use of PROA was administered to members of PROA teams in our hospital network. The survey was conducted at 26 hospitals. Twelve percent of the hospitals had pediatric PROA in operation, 42% were included in adult PROA, and 46% carried out pediatric PROA activities but not as part of an established program. At 81%, the pediatric PROA team included a pediatrician, in 58% a pharmacist, and in 54% a microbiologist. The main activities were monitoring the use of antimicrobials and bacterial resistance. Twenty-seven percent measured indicators regularly. The VINCat Pediatric PROA group’s hospitals have implemented measures for optimizing antimicrobial stewardship, but few have a pediatric PROA program in place. Specific measures and indicators must be defined, and the resources available should be increased. The development of pediatric PROA should be monitored in the coming years.